80 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35007692 | Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain. | 2022 Jan 8 | 1 |
2 | 35381286 | In vitro characterization and molecular dynamics simulation reveal mechanism of 14-3-3ζ regulated phase separation of the tau protein. | 2022 May 31 | 2 |
3 | 33452693 | Interplay between tau and α-synuclein liquid-liquid phase separation. | 2021 Jul | 2 |
4 | 33459229 | GSK-3 Inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment. | 2021 | 1 |
5 | 33663205 | Uncovering the Effect of pS202/pT205/pS208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein. | 2021 Mar 17 | 1 |
6 | 33680370 | Role of Phosphorylation and Hyperphosphorylation of Tau in Its Interaction with βα Dimeric Tubulin Studied from a Bioinformatics Perspective. | 2021 Jan-Mar | 2 |
7 | 33794133 | Interaction between the guanylate kinase domain of PSD-95 and the proline-rich region and microtubule binding repeats 2 and 3 of tau. | 2021 Oct | 1 |
8 | 34310938 | Disease-associated mutations affect TIA1 phase separation and aggregation in a proline-dependent manner. | 2021 Oct 1 | 1 |
9 | 34473990 | Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture. | 2021 Oct | 1 |
10 | 34559968 | Probing the Internal Dynamics and Shape of Simple Peptides in Urea, Guanidinium Hydrochloride, and Proline Solutions with Time-Resolved Fluorescence Anisotropy and Atomistic Cosolvent Simulations. | 2021 Oct 7 | 1 |
11 | 31698056 | A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity. | 2020 Feb | 2 |
12 | 32126198 | Tau Reduction Prevents Key Features of Autism in Mouse Models. | 2020 May 6 | 2 |
13 | 32997736 | The proline-rich domain promotes Tau liquid-liquid phase separation in cells. | 2020 Nov 2 | 1 |
14 | 33110983 | Machine Learning for Discovery of GSK3β Inhibitors. | 2020 Oct 20 | 1 |
15 | 33148293 | Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease. | 2020 Nov 4 | 2 |
16 | 33188775 | Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease. | 2020 Dec 10 | 1 |
17 | 33273615 | Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils. | 2020 Dec 3 | 2 |
18 | 31112821 | Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay. | 2019 Jul | 4 |
19 | 31358628 | In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments. | 2019 Aug 13 | 1 |
20 | 31399291 | A Possible Neurodegeneration Mechanism Triggered by Diabetes. | 2019 Oct | 1 |
21 | 31699899 | Independent tubulin binding and polymerization by the proline-rich region of Tau is regulated by Tau's N-terminal domain. | 2019 Dec 13 | 3 |
22 | 30318466 | Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody. | 2018 Dec 4 | 2 |
23 | 28341999 | Immunological memory to hyperphosphorylated tau in asymptomatic individuals. | 2017 May | 1 |
24 | 29051562 | Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects. | 2017 Oct 19 | 2 |
25 | 27193083 | Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease. | 2016 May 18 | 2 |
26 | 25467137 | Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease. | 2015 Jan 15 | 3 |
27 | 25628064 | The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease. | 2015 Apr | 1 |
28 | 26502977 | Analysis of in vivo turnover of tau in a mouse model of tauopathy. | 2015 Oct 26 | 2 |
29 | 24559475 | OGlcNAcylation and phosphorylation have opposing structural effects in tau: phosphothreonine induces particular conformational order. | 2014 Mar 12 | 1 |
30 | 23362255 | Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. | 2013 Mar 15 | 2 |
31 | 23979027 | TOC1: characterization of a selective oligomeric tau antibody. | 2013 | 1 |
32 | 22235112 | γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation. | 2012 Feb 24 | 3 |
33 | 22464332 | Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. | 2012 Mar 30 | 1 |
34 | 21056617 | Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease. | 2011 Jan | 2 |
35 | 21489990 | Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain. | 2011 Jun 10 | 8 |
36 | 21514440 | Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease. | 2011 May | 2 |
37 | 21910444 | Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau. | 2011 Oct 12 | 1 |
38 | 20160454 | 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy. | 2010 | 1 |
39 | 19074508 | Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules. | 2009 Apr | 1 |
40 | 18199773 | The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. | 2008 Jan 16 | 3 |
41 | 18725412 | Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. | 2008 Nov 14 | 3 |
42 | 17908042 | N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy. | 2007 Sep | 1 |
43 | 18220518 | Inhibition of tau aggregation in cell models of tauopathy. | 2007 Dec | 3 |
44 | 16772869 | Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. | 2006 May | 2 |
45 | 15615649 | Tau and src family tyrosine kinases. | 2005 Jan 3 | 2 |
46 | 16024764 | Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. | 2005 Jun | 2 |
47 | 16095818 | DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease. | 2005 Dec 2 | 1 |
48 | 14660656 | Comparative vibrational spectroscopy of intracellular tau and extracellular collagen I reveals parallels of gelation and fibrillar structure. | 2004 Feb 27 | 2 |
49 | 11248668 | The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. | 2001 Mar | 1 |
50 | 11550225 | Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells. | 2001 Sep 15 | 2 |